Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group
- PMID: 7724748
- DOI: 10.1148/radiology.195.2.7724748
Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group
Abstract
Purpose: To compare findings with computed tomography (CT) and magnetic resonance (MR) imaging in pancreatic adenocarcinoma and to determine optimal pulse sequences for MR imaging.
Materials and methods: CT scans and MR images were compared of 189 adult patients with known or suspected adenocarcinoma of the pancreas. Levels of confidence were correlated with surgical and pathologic results.
Results: The accuracy of CT was 0.73 and of MR imaging was 0.70. The negative predictive value of CT was 0.28 and of MR imaging was 0.23. The positive predictive value of CT was 0.89 and of MR imaging was 0.88. Gradient-echo and T1-weighted spin-echo sequences ranked equally in evaluation of vascular invasion, T1-weighted spin-echo sequences were preferred for assessing lymphadenopathy, and T2-weighted spin-echo sequences were preferred for detecting hepatic metastases.
Conclusions: Cross-sectional imaging modalities are useful in the identification of unresectable pancreatic carcinoma. CT is recommended for initial imaging assessment.
Similar articles
-
Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.AJR Am J Roentgenol. 1994 Feb;162(2):315-23. doi: 10.2214/ajr.162.2.8310918. AJR Am J Roentgenol. 1994. PMID: 8310918
-
Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis.AJR Am J Roentgenol. 1999 Sep;173(3):583-90. doi: 10.2214/ajr.173.3.10470884. AJR Am J Roentgenol. 1999. PMID: 10470884
-
Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil.AJR Am J Roentgenol. 1996 Oct;167(4):997-1001. doi: 10.2214/ajr.167.4.8819400. AJR Am J Roentgenol. 1996. PMID: 8819400
-
Imaging of pancreatic adenocarcinoma: update on staging/resectability.Radiol Clin North Am. 2012 May;50(3):407-28. doi: 10.1016/j.rcl.2012.03.008. Epub 2012 Apr 6. Radiol Clin North Am. 2012. PMID: 22560689 Review.
-
MR imaging of pancreatic disorders.Top Magn Reson Imaging. 1996 Oct;8(5):265-89. Top Magn Reson Imaging. 1996. PMID: 8914226 Review.
Cited by
-
Pancreatic adenocarcinoma.Eur Radiol. 2007 Mar;17(3):638-49. doi: 10.1007/s00330-006-0435-7. Epub 2006 Oct 5. Eur Radiol. 2007. PMID: 17021700 Review.
-
Management of upper gastrointestinal cancers.Qual Health Care. 2001 Mar;10(1):57-64. doi: 10.1136/qhc.10.1.57. Qual Health Care. 2001. PMID: 11239144 Free PMC article. Review. No abstract available.
-
Functional magnetic resonance imaging in an animal model of pancreatic cancer.World J Gastroenterol. 2010 Jul 14;16(26):3292-8. doi: 10.3748/wjg.v16.i26.3292. World J Gastroenterol. 2010. PMID: 20614485 Free PMC article.
-
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.Eur J Nucl Med. 1996 Dec;23(12):1641-74. doi: 10.1007/BF01249629. Eur J Nucl Med. 1996. PMID: 8929320 Review.
-
Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications.Biomed Res Int. 2015;2015:269641. doi: 10.1155/2015/269641. Epub 2015 Jun 4. Biomed Res Int. 2015. PMID: 26146615 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
